Citation 88824

TAKAHASHI,K: SUZUKI,S: HANO,Y: NOMURA,T:. (2002). PROTEIN KINASE C ACTIVATION BY IRIDAL TYPE TRITERPENOIDS.. 25(4)

Citation Details

Title	PROTEIN KINASE C ACTIVATION BY IRIDAL TYPE TRITERPENOIDS.
Authors	TAKAHASHI,K: SUZUKI,S: HANO,Y: NOMURA,T:
Year	2002
Volume	25
Issue	4

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (3)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	BELAMCANDAL,28-DEACETYL:	ACTIVE
2	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BELAMCANDAL,28-DEACETYL:	ACTIVE
3	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL B	ACTIVE
4	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL B	ACTIVE
5	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROIRID-16-ENAL,26-HYDROXY-15-METHYLENE:	ACTIVE
6	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROIRID-16-ENAL,26-HYDROXY-15-METHYLENE:	ACTIVE
7	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOGERMANAL,ISO: 16-O-ACETYL:	ACTIVE
8	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOGERMANAL,ISO: 16-O-ACETYL:	ACTIVE
9	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOGERMANAL,ISO:	ACTIVE
10	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOGERMANAL,ISO:	ACTIVE
11	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOBELAMAL A	INACTIVE
12	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOBELAMAL A	INACTIVE
13	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROIRID-16-ENAL,EPSILON-HYDROXY-13(R)-OXA: 6(R)-10(S)-11(R):	ACTIVE
14	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROIRID-16-ENAL,EPSILON-HYDROXY-13(R)-OXA: 6(R)-10(S)-11(R):	ACTIVE
15	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL A	ACTIVE
16	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL A	ACTIVE

Iris tectorum (IRIDACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	IRIDOTECTORAL C	None
2	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL C	ACTIVE
3	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL C	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	IRIDOTECTORAL D	None
5	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL D	INACTIVE
6	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOTECTORAL D	INACTIVE

Belamcanda chinensis (IRIDACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	IRIDOBELAMAL B	None
2	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOBELAMAL B	ACTIVE
3	PROTEIN KINASE C BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	IRIDOBELAMAL B	ACTIVE

Show SPARQL Queries (1)